Exosomal miR-21 from NSCLC cells facilitates osteoclastogenesis by targeting PDCD4 [30] and inhibition of miR-21 impairs osteoclast activity in multiple myeloma by targeting OPG and PIAS3 [152]. This evidence concerns the gene TNFRSF11B and plasma cell myeloma.